Drug interactions
Carfilzomib + Ropeginterferon alfa 2b
Severity: Major
Carfilzomib and Ropeginterferon alfa 2b: major interaction.
Last updated Sources: US FDA label
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Summary
Both agents can suppress the bone marrow. The combination may cause additive thrombocytopenia, neutropenia and anemia.
What this interaction means in plain words
Carfilzomib and Ropeginterferon alfa 2b can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.
Why it happens
Additive myelosuppression through distinct pharmacodynamic effects.
What to do
Monitor full blood counts frequently and adjust or hold doses for significant cytopenias.
What to ask your pharmacist
- Does the benefit of taking both outweigh the risk in my case?
- Do I need any blood test, ECG or other check while on both?
- What early warning signs should I watch for, and what should I do if they appear?
Pro+ members
Unlock the full page
Create an account and start a Pro+ trial to unlock the full management advice for Carfilzomib and Ropeginterferon alfa 2b, the additional notes, the evidence detail and the whole-prescription interaction checker.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Try Pro+ free for 7 days on the web. No card needed.
References
Other interactions of Carfilzomib
- Carfilzomib + Etrasimod Major
- Carfilzomib + Dichlorphenamide Moderate
- Carfilzomib + Palifermin Moderate
- Carfilzomib + Ponesimod Moderate
- Carfilzomib + Siponimod Moderate
- Berotralstat + Carfilzomib Minor
Frequently asked questions
Can I take Carfilzomib with Ropeginterferon alfa 2b?
MediHelp rates the interaction as major. Carfilzomib and Ropeginterferon alfa 2b can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Both agents can suppress the bone marrow. The combination may cause additive thrombocytopenia, neutropenia and anemia.
How serious is the interaction between Carfilzomib and Ropeginterferon alfa 2b?
MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor full blood counts frequently and adjust or hold doses for significant cytopenias.
What other medicines interact with Carfilzomib?
MediHelp also lists interactions of Carfilzomib with, for example, Etrasimod, Dichlorphenamide, Palifermin. The full list is on the Carfilzomib page.
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.
